Ergomed (ERGO)

 

ERGO Share PerformanceMore

52 week high216.90 28/02/17
52 week low117.00 16/09/16
52 week change 71.10 (53.04%)
4 week volume529,298 29/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Appointment of N+1 Singer as joint broker

RNS Number: 7234F Ergomed plc 22 May 2017 PRESS RELEASE FOR IMMEDIATE RELEASE Appointment of N+1 Singer as joint broker London, UK - 22 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today annou...

Annual Report and Notice of AGM

RNS Number: 0569F Ergomed plc 12 May 2017 Annual Report and Notice of AGM London, UK - 12 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, today announces that it will hold its Annual General Meeting at the off...

Ergomed updates in PharmInvent earn-out

Ergomed has confirmed that the conditions for the issue of 94,618 additional new ordinary shares to former shareholders o...

Issue of Shares to Former PharmInvent Shareholders

RNS Number: 4782E Ergomed plc 08 May 2017 PRESS RELEASE FOR IMMEDIATE RELEASE 8 MAY 2017 Ergomed Issues First Earn-Out Shares to Former Shareholders of PharmInvent London, UK - 8 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated to the provision of specialised services to the pharmaceutical industry ...

Broker Forecast - Stifel issues a broker note on Ergomed Plc

Stifel today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and cut its price target to 304p (from 315p).

Broker Forecast - Numis issues a broker note on Ergomed Plc

Numis today reaffirms its buy investment rating on Ergomed Plc (LON:ERGO) and cut its price target to 275p (from 300...

Co-Development Partner News

RNS Number: 8032D Ergomed plc 02 May 2017 PRESS RELEASE FOR IMMEDIATE RELEASE Ergomed notes announcement by co-development partner, Aeterna Zentaris, of results from Phase 3 clinical trial with Zoptrex in advanced endometrial cancer London, UK - 02 May 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a company dedicated t...

11 shares where positive earnings shocks could trigger rallies

Companies that beat profit forecasts tend to rally over the next few months, so Stockopedia's Ben Hobson reveals the bigges...

Fundamental DataMore

P/E ratio157.754
EPS1.3
Dividend yield0 %

Equity Research (ERGO)

equity development
Ergomed Plc
08/05/2017
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. Aeterna Zentaris, a co-development partner of...
equity development
Ergomed Plc
12/04/2017
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. 2016 perfectly highlighted the strengths of the...
equity development
Ergomed Plc
25/01/2017
Ergomed offers clinical trial and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies. The recent period end update for Ergomed confirmed...

Latest discussion posts More

  • Results webinar

    If you would like to hear management present the preliminary results for the year ended 31 December 2016 for Ergomed we will be hosting a webinar on Wednesday 29th March at ...
    22-Mar-2017
    equity_dev
  • See management present

    If you would like to hear Stephen Stamp, Chief Finance Officer, present on behalf of Ergomed he will be appearing at our next investor forum on the evening of Wednesday 25th of ...
    17-Jan-2017
    equity_dev
  • Webinar with management

    We will be hosting a webinar with the management of Ergomed tomorrow (Tuesday 27th September) at 11.15. There will be a presentation of the interim results lasting around ...
    26-Sep-2016
    equity_dev

Users' HoldingsMore

Users who hold Ergomed also hold..
ID:ISIN:VGG9828A119433%
CENTRAL ASIA33%
LLOYDS GRP.33%
FEVERTREE DRK33%
GEMFIELDS33%

Codes & Symbols

ISINGB00BN7ZCY67
SymbolsERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO